Literature DB >> 17171138

Hearing preservation after acoustic neuroma surgery.

V J Jaisinghani, S C Levine, E Nussbaum, S Haines, B Lindgren.   

Abstract

Acoustic neuromas (AN) are benign tumors that arise from the vestibular nerve within the internal auditory canal, where hearing loss is the most common symptom. This retrospective study was done to determine the results of hearing preservation in patients operated for AN at the University of Minnesota, as well as the factors affecting them. One hundred-eighty patients with AN were operated between 1988 and 1998, of whom 91 (50.5%) underwent hearing preservation surgery by either the middle fossa (MF) or the suboccipital (SO) approach. Preoperative and postoperative pure-tone averages (1, 2, and 4 K), speech discrimination scores (SDS), and acoustic reflex thresholds (ART) were noted and classified according to the Shelton's and the Gardner's classifications. The overall rate of hearing preservation was 23.1%. The outcome of hearing results was better with the MF approach compared with the SO approach. Small tumor size and better preoperative hearing levels favored a better postoperative hearing result. The rate of hearing improvement over time was better for the MF patients. Patients for whom intraoperative auditory monitoring was performed seemed to have better hearing outcomes.

Entities:  

Year:  2000        PMID: 17171138      PMCID: PMC1656822          DOI: 10.1055/s-2000-9510

Source DB:  PubMed          Journal:  Skull Base Surg        ISSN: 1052-1453


  26 in total

Review 1.  Hearing preservation in the removal of intracanalicular acoustic neuromas via the retrosigmoid approach.

Authors:  D W Rowed; J M Nedzelski
Journal:  J Neurosurg       Date:  1997-03       Impact factor: 5.115

2.  Middle fossa acoustic tumor surgery: results in 106 cases.

Authors:  C Shelton; D E Brackmann; W F House; W E Hitselberger
Journal:  Laryngoscope       Date:  1989-04       Impact factor: 3.325

3.  Technique of hearing preservation in small acoustic neuromas.

Authors:  P J Jannetta; A R Møller; M B Møller
Journal:  Ann Surg       Date:  1984-10       Impact factor: 12.969

Review 4.  Preservation of hearing in surgery for acoustic neuromas.

Authors:  M E Glasscock; J W Hays; L B Minor; D S Haynes; V N Carrasco
Journal:  J Neurosurg       Date:  1993-06       Impact factor: 5.115

5.  Hearing preservation in acoustic neuroma surgery: value of monitoring cochlear nerve action potentials.

Authors:  J M Nedzelski; C M Chiong; M Z Cashman; S G Stanton; D W Rowed
Journal:  Otolaryngol Head Neck Surg       Date:  1994-12       Impact factor: 3.497

6.  Hearing preservation in acoustic tumor surgery: results and prognostic factors.

Authors:  J L Dornhoffer; J Helms; D H Hoehmann
Journal:  Laryngoscope       Date:  1995-02       Impact factor: 3.325

7.  Improvement of hearing after microsurgical removal of acoustic neurinoma.

Authors:  G Fischer; J L Costantini; P Mercier
Journal:  Neurosurgery       Date:  1980-08       Impact factor: 4.654

8.  Hearing preservation after removal of acoustic neurinoma.

Authors:  S G Harner; E R Laws; B M Onofrio
Journal:  Laryngoscope       Date:  1984-11       Impact factor: 3.325

9.  Use of intraoperative auditory evoked potentials to preserve hearing in unilateral acoustic neuroma removal.

Authors:  R G Ojemann; R A Levine; W M Montgomery; P McGaffigan
Journal:  J Neurosurg       Date:  1984-11       Impact factor: 5.115

10.  Hearing preservation after acoustic neuroma surgery using intraoperative direct eighth cranial nerve monitoring.

Authors:  H Silverstein; A B McDaniel; H Norrell
Journal:  Am J Otol       Date:  1985-11
View more
  2 in total

1.  Auditory Brain Stem Response Predictors of Hearing Outcomes after Middle Fossa Resection of Vestibular Schwannomas.

Authors:  Yin Ren; Catherine M Merna; Kareem O Tawfik; Marc S Schwartz; Rick A Friedman
Journal:  J Neurol Surg B Skull Base       Date:  2021-01-21

2.  Insertion of intra-oral electrodes for cranial nerve monitoring using a Crowe-Davis retractor.

Authors:  Terrence L Trentman; Christopher Thunberg; Andrew Gorlin; Antoun Koht; Richard S Zimmerman; Bernard Bendok
Journal:  J Clin Monit Comput       Date:  2016-07-05       Impact factor: 2.502

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.